Expanded access, also known as compassionate use, is a process by which a patient can petition both the maker of an experimental treatment and the US Food and Drug Administration for access to the treatment outside a clinical trial. The Regan-Udall Foundation has created an Expanded Access Navigator to educate patients and their physicians about the process and to help locate necessary information for application. The Navigator is separated into sections specifically for patients and physicians, so that information can be found more quickly. For more information about the Expanded Access Navigator, click here: http://bit.ly/2tGlNjV
- Free WCG Foundation webinars offer insights on speeding access to experimental drugs for intermediate-size patient populations
- Do supercentenarians, people who live to 110 years and older, have something special in their genetic code?
- To call in or go in to work when sick? This time of year, that’s the question.
- Could #breastcancer be prevented from spreading to the brain?
- #AntibioticResistance could lead to dangerous outcomes. What can be done to prevent this?